BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2663408)

  • 1. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment.
    Rozman K
    Derm Beruf Umwelt; 1989; 37(3):81-92. PubMed ID: 2663408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD).
    Kociba RJ; Schwetz BA
    Drug Metab Rev; 1982; 13(3):387-406. PubMed ID: 6213397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of dioxin toxicity: relationship to risk assessment.
    Birnbaum LS
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):157-67. PubMed ID: 7698077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed occupational exposure limit for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Leung HW; Murray FJ; Paustenbach DJ
    Am Ind Hyg Assoc J; 1988 Sep; 49(9):466-74. PubMed ID: 2972183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosterone decreases toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in hypophysectomized rats.
    Gorski JR; Lebofsky M; Rozman K
    J Toxicol Environ Health; 1988; 25(3):349-60. PubMed ID: 3184202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: environmental contaminant and molecular probe.
    Poland A; Kende A
    Fed Proc; 1976 Oct; 35(12):2404-11. PubMed ID: 134910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster.
    Madhukar BV; Brewster DW; Matsumura F
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7407-11. PubMed ID: 6095293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in chemical workers after chloracne and in comparison groups.
    Neuberger M; Landvoigt W; Derntl F
    Int Arch Occup Environ Health; 1991; 63(5):325-7. PubMed ID: 1837285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as a potent and persistent thyroxine agonist: a mechanistic model for toxicity based on molecular reactivity.
    McKinney JD; Fawkes J; Jordan S; Chae K; Oatley S; Coleman RE; Briner W
    Environ Health Perspect; 1985 Sep; 61():41-53. PubMed ID: 2998749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further discussion concerning porphyria cutanea tarda and TCDD exposure.
    Jones RE; Chelsky M
    Arch Environ Health; 1986; 41(2):100-3. PubMed ID: 3521500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency.
    Flodström S; Busk L; Kronevi T; Ahlborg UG
    Fundam Appl Toxicol; 1991 Feb; 16(2):375-91. PubMed ID: 2055368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical examination of assumptions used in risk assessments of dioxin contaminated soil.
    Paustenbach DJ; Shu HP; Murray FJ
    Regul Toxicol Pharmacol; 1986 Sep; 6(3):284-307. PubMed ID: 3775086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of the use of mutagenesis, carcinogenesis, and tumor promotion data in a cancer risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Shu HP; Paustenbach DJ; Murray FJ
    Regul Toxicol Pharmacol; 1987 Mar; 7(1):57-88. PubMed ID: 3575798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies.
    Greene JF; Hays S; Paustenbach D
    J Toxicol Environ Health B Crit Rev; 2003; 6(2):115-59. PubMed ID: 12554432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism.
    Couture LA; Abbott BD; Birnbaum LS
    Teratology; 1990 Dec; 42(6):619-27. PubMed ID: 2087682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the toxicity of 2,3,7,8-TCDD.
    Rohleder F
    Derm Beruf Umwelt; 1990; 38(3):94-5. PubMed ID: 2376241
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological effects of chlorinated dibenzo-p-dioxins.
    Kerkvliet NI
    Environ Health Perspect; 1995 Dec; 103 Suppl 9(Suppl 9):47-53. PubMed ID: 8635439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice.
    Weber LW; Lebofsky M; Stahl BU; Smith S; Rozman KK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):155-62. PubMed ID: 7878671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced gluconeogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Gorski JR; Weber LW; Rozman K
    Arch Toxicol; 1990; 64(1):66-71. PubMed ID: 2306197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.